Day 1 - From Downloads to Decisions: How AXS26 Day 1 Redefined Success in Patient Affordability
Las Vegas has a way of amplifying energy, and Day 1 of Asembia Specialty Pharmacy Summit at Wynn & Encore Las Vegas didn’t disappoint. The floors were buzzing—not with small talk, but with a conversation the industry has been circling for years: are affordability programs actually working, or are we just measuring the wrong things?
That tension set the tone for everything.
On the ground, the Product Theater drew a packed room and an even sharper discussion. The opening session, “The Download Trap: Why Affordability Programs Need New Success Metrics,” cut straight to the point. Moderated by Vijay Adapala, Chief Business Development Officer, Doceree, alongside Nicolas Kernick, Head of Growth & Operations, Develop Health, Kevin Boesen, Chief Commercial Officer, Outcomes Health, and Jeff Davis, VP – Sales, Life Sciences, NimbleRx, the panel made one thing clear—downloads and registrations are vanity metrics. What matters is whether patients actually fill prescriptions and stay on therapy.
The fireside chat that followed, moderated by Andrew Matthews, SVP – Sales, Patient Affordability Solutions, Doceree, with Daniel Keene, VP – Head of US Patient Services, Alnylam, pushed the conversation further into practical territory. How do you build affordability strategies that hold up inside complex organizations while still moving the needle for real patients? No easy answers—but the right questions are finally being asked out loud.
Closing the session, Thomas Shea, Chief Revenue Officer, Doceree, brought it back to execution: simplify co-pay discovery, reduce friction at activation, and get patients to therapy faster. It sounds obvious—and yet it remains one of the industry’s most persistent gaps.
What stood out wasn’t any single session, but the shift in language. “Accountability” came up more than once. Success is no longer about engagement rates; it’s about whether a patient started—and stayed—on treatment.
If Day 1 is any signal, AXS26 isn’t just revisiting old problems—it’s demanding better answers. And as the conversation deepens over the coming days, the focus will only sharpen: turning intent into action, and access into measurable impact.
Get ready for Day 2—where these conversations move from perspective to progression.
More from the floor tomorrow.
Day 2 — Booth #1834 Was the Center of Gravity on the Floor
If Day 1 asked the right questions, Day 2 started answering them.
The energy on the floor shifted noticeably — less introductory, more transactional. Pharma leaders, access teams, and ecosystem partners weren't just browsing; they were looking for solutions they could take back to their organizations.
It was clear Doceree’s Booth #1834 wasn't just another stop on the floor; it was the stop. A consistent flow of industry leaders, pharmacy directors, and senior pharma executives made their way over, and conversations rarely stayed short. What started as quick check-ins turned into standing discussions that spilled past scheduled times. The energy was hard to miss and harder to walk past.
The throughline across nearly every interaction? Affordability programs that look good on paper but lose patients somewhere between awareness and the pharmacy counter. That's exactly where co-pay.com cut through. What started as a conversation in the Product Theater on Day 1 clearly carried into Day 2, with many attendees coming to the booth to continue that dialogue.
The response wasn't polite interest—it was recognition. The idea that co-pay success doesn’t stop at download but starts at activation resonated instantly, because it reflects where most programs fall short today. People have been sitting with this problem for a while.
What stood out most was a quiet but significant shift in how affordability is being positioned. It's no longer a support function tucked under patient services; it's earning a seat at the table where access strategies are actually built. And that changes what good looks like.
The questions were sharper. The urgency felt real. And the momentum? Undeniable.
Day 3 doesn't just continue the conversation; it's where the industry decides what happens next.
Asembia AXS26: Day 3 - From Conversations to Creating Change
Day 3: If Day 2 built momentum, Day 3 turned it into a firm intention.
After a high-energy evening at Topgolf that brought a more informal, connected close to the day, the tone on the floor the next morning felt different: more focused and deliberate. The conversations weren’t just continuing; they were evolving to address the needs of the hour.
Doceree’s Booth #1834 once again drew a steady stream of industry leaders, but the nature of engagement had shifted. This wasn’t about discovery anymore. It was about understanding how to plug in. co-pay.com became the center of that dialogue.
What stood out wasn’t just interest; it was urgency to be a part of the change. Leaders across pharma access and patient support weren’t asking what the solution is; they were asking how it fits into their ecosystems. How does this integrate? How quickly can it scale? What does success actually look like beyond activation?
Because by now, the problem was clear to everyone.
Affordability programs weren’t failing due to a lack of awareness; they’re breaking at the point of action. And what co-pay.com is building isn’t just a fix; it’s a shift toward making affordability truly accessible, measurable, and embedded into the care journey.
That’s what made Day 3 different.
The conversations became more honest. The barriers were more openly acknowledged. And most importantly, the willingness to rethink existing approaches felt real.
If Day 1 questioned the system, and Day 2 started solving for it, Day 3 showed how the industry was ready to be part of the change. And from the floor at Doceree’s Booth #1834, it was clear that this isn’t where the conversation ends. It’s where it starts taking shape.
Day 3 had set in motion that this is only the start of a larger transformation in affordability, adherence, and patient care and outcomes and we are excited to see what Day 4 brings to the table.